We also showed that a subset of human cancers exhibited reduced NEIL1 and NEIL2 expression levels and an elevated NEIL3 expression level, and these abnormal expressions of NEIL1, NEIL2, and NEIL3 were associated with the mutation load in cancer. Here, NEIL1 is linked to cancer.